Trade groups, manufacturers and patients alike weighed in on a pair of US FDA draft guidance documents that were issued in January to address manufacturer communications, with 110 comments collected before the April 19 deadline and posted online this week.
The agency collected 86 comments on a draft guidance on manufacturers’ communications about unapproved uses of medical products, with an additional 24 comments coming in response to a guidance about...